MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition
Grigorios Theodoropoulos, Evangelos Tsiambas, Paraskevi Tziakou, Despoina Spyropoulou, Athanasios Niotis, Harikleia Gakiopoulou, Odysseas Dimas, Loukas Manaios, Andreas C Lazaris, Georgia Thomopoulou; pp 2209-2212 (Pubmed Abstract, PDF)

Induction chemotherapy in head and neck cancers – old actors, new horizons
Camil Ciprian Mirestean, Roxana Irina Iancu, Dragos Teodor Petru Iancu; pp 2213-2217 (Pubmed Abstract, PDF)

Surgical management in hepatocellular carcinoma with portal vein tumor thrombosis: Is this the end of the road or a chance to expand the criteria for resectability?
Nikolaos Benetatos, Iliana Papadopoulou, Stelios F. Assimakopoulos, Evangelos Iliopoulos, Stylianos Germanos, Michail Vailas, Maria Sotiropoulou, Panagiotis Kitrou, Konstantinos Katsanos, Christina Kalogeropoulou, Ioannis Maroulis; pp 2218-2226 (Pubmed Abstract, PDF)

Biomarkers and common oral cancers: Clinical trial studies
Emran Hajmohammadi, Saina Ghahremanie, Mostafa Alam, Kamyar Abbasi, Fatemeh Mohamadian, Danial Khayatan, Hamid Tebyaniyan, Mahdi Rahbar; pp 2227-2237 (Pubmed Abstract, PDF)

BREAST CANCER

Correlation between ultrasound guided staining margin and survival rate, recurrence rate and cosmetic effect of breast cancer patients
Liyuan Ma, Haigen Xi, Guangfei Yang, Qianfeng Ma, Bo Wu, Tao Jiang; pp 2238-2244 (Pubmed Abstract, PDF)

The prevalence and prognostic importance of the androgen receptor in triple-negative breast cancer
Elif Sila Erim, Gurdeniz Serin, Ulus Ali Sanli, Erhan Gokmen, Osman Zekioglu, Burcu Cakar; pp 2245-2251 (Pubmed Abstract, PDF)

Risk reducing mastectomy in patients with and without gene mutation: experience in an Italian Breast Unit
Daniele La Forgia, Sergio Diotaiuti, Rossana Altieri, Nicola Cortese, Maria Digennaro, Annarita Fanizzi, Margherita Patruno, Raffaella Massafra, Angelo Virgilio Paradiso; pp 2252-2257 (Pubmed Abstract, PDF)

Fibroblast growth factor-23 in HER2 positive breast cancer: its expression and correlation with adjuvant EC -> D+T treatment induced cardiotoxicity risk
Qian Zhang, Dengfeng Chen; pp 2258-2265 (Pubmed Abstract, PDF)

Correlation between clinicopathologic factors and recurrence score according to TAILOR x risk category in patients with hormone receptor positive early-stage breast cancer
Kezban Nur Pilanci, Caglar Unal, Cetin Ordu, Erhan Gokmen, Mustafa Ozdogan, Nilufer Guler, Cihan Uras, Orhan Demircan, Abdurrahman Isikdogan, Halil Kara, Abdullah Bahadir Oz, Gul Alco, Pinar Saip,Yesim Eralp,Vahit Ozmen; pp 2266-2273 (Pubmed Abstract, PDF)

A new predictive marker for predicting response after neoadjuvant chemotherapy in hormone receptor positive/HER2-negative patients: a logarithmic model
Yakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, Seher Yildiz Tacar, Halil Taskaynatan, Okan Avci, Ahmet Yolcu, Sibel Ozkan Gurdal, Meltem Oznur, Erdogan Selcuk Seber; pp 2274-2281 (Pubmed Abstract, PDF)

Clinical and histopathological characteristics of male breast cancer: A single center experience
Gulnihan Kupik, Osman Kupik, Kadri Altundag; pp 2282-2287 (Pubmed Abstract, PDF)

The effect of boost radiotherapy on local control in ductal carcinoma in-situ of the breast: Retrospective single-center experience with literature review
Ahmet Serkan Ilgun, Gul Alco, Alper Ozturk, Filiz Celebi, Zeynep Erdogan, Cetin Ordu, Fatma Aktepe, Gursel Soybir, Vahit Ozmen; pp 2288-2295 (Pubmed Abstract, PDF)

The contributory role of multidisciplinary meetings in the diagnosis and treatment of breast cancer
Binnur Donmez Yilmaz, Semra Gunay, Asli Erturk, Aysun Arslantas, Pinar Ozay Nayir, Sevda Saglampinar Karyagar, Biray Erturk, Sener Cihan; pp 2296-2301 (Pubmed Abstract, PDF)

miR-301a-5p negatively affects Treg and Th17 related gene expression in contrast to miR-21 and miR-23b-5p in early-stage breast tumor tissue
Lyuba Miteva, Stoyan Nikolov, Noyko Stanilov, Petio Chilingirov, Spaska Stanilova; pp 2302-2310 (Pubmed Abstract, PDF)

GYNECOLOGIC CANCERS

Supportive care needs, psychological distress and social support of patients with gynecologic cancer before surgery
Konstantina Menti, Ourania Govina, Eleni Dokoutsidou, Theocharis Konstantinidis, Andreas Charalambous, Theodoula Adamakidou; pp 2311-2319 (Pubmed Abstract, PDF)

Efficacy of transumbilical laparoendoscopic single-site staging surgery in treating endometrial cancer
Yanyan Dou, Xiangmei Zheng; pp 2320-2326 (Pubmed Abstract, PDF)

Ovarian cystectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy: a randomized controlled trial
Jing Li, Manzhu He, Tao Hou; pp 2327-2334 (Pubmed Abstract, PDF)

CircMUC16 activates AKT3 pathway to promote the malignant progression of cervical cancer
Qinwei Zhang, Fang Zhang, Yaner Dong, Youchun Ye, Zhongna Yu; pp 2335-2342 (Pubmed Abstract, PDF)

Fucoidan inhibits ovarian cancer growth via the miR-20a-5p/PKD2 axis
Ziqi Cheng, Yapei Lu, Yuan Fang; pp 2343-2349 (Pubmed Abstract, PDF)

Lidocaine for ovarian cancer. Preclinical in vitro data
Razvan Popa, Diana Cenariu, Ancuta Jurj, Noemi Dirzu, Sergiu Pasca, Tiberiu Tat, Daniela Ionescu, Alexandru Irimie; pp 2350-2357 (Pubmed Abstract, PDF)

CUL4B/KLF11 axis promotes malignant ovarian cancer progression
Yapei Lu, Ziqi Cheng; pp 2358-2364 (Pubmed Abstract, PDF)

The best evidence for the prevention and management of lower extremity deep venous thrombosis after gynecological malignant tumor surgery: A systematic review and network meta-analysis
Jiaqi Hu, Yidan Geng, Jingyi Ma, Xuefan Dong, Shuqin Fang, Jianli Tian; pp 2365-2372 (Pubmed Abstract, PDF)

LIVER CANCER

MiR-378a-3p represses malignant behaviors in liver hepatocellular carcinoma via targeting SIRT6
Geqiong Xiao, Hui Liao, Mengyu Ding, Qiong Wang, Wenwen Zhu, Jian Chang, Liang Wang; pp 2373-2382 (Pubmed Abstract, PDF)

LncRNA00978 contributes to cells growth and metastasis in hepatocellular carcinoma via mediating miR-125b-5p/SOX12 pathway
Zhiqing Cheng, Limei Gong, Shan Lin, Xiaojie Jiang, Qinghe Cai; pp 2385-2394 (Pubmed Abstract, PDF)

CircFMN2 boosts sorafenib resistance in hepatocellular carcinoma cells via up-regulating CNBP by restraining ubiquitination
Chen Fan, Xiaoli Zhu, Qi Zhou, Weidong Wang; pp 2395-2403 (Pubmed Abstract, PDF)

PCGEM1 triggers liver cancer progression by positively regulating SNAI1
Yong Wang, Chen Chen, Xintian Wang, Chao Jiang; pp 2404-2410 (Pubmed Abstract, PDF)

Non-alcoholic fatty liver disease and extra-hepatic malignancies
Tudor Cuciureanu, Carol Stanciu, Sebastian Zenovia, Cristina M. Muzica, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Catalin Sfarti, Vladut Mirel Burduloi, Anca Trifan; pp 2411-2414 (Pubmed Abstract, PDF)

COLORECTAL CANCERS

Outcomes of laparoscopic complete mesocolic excision for transverse colon cancer in elderly patients
Jianhua Dong, Xianshuo Cheng, Ming Li, Kun Yu; pp 2415-2422 (Pubmed Abstract, PDF)

Capecitabine combined with bevacizumab in maintenance therapy of metastatic colorectal cancer: a retrospective clinical study
Jianhua Zhu, Wei Xu, Wei Tang; pp 2423-2429 (Pubmed Abstract, PDF)

PLA2G3 phospholipase expression patterns in colon adenocarcinoma
Evangelos Falidas, Eirini Kitsiouli, Dimitrios Tsounis, Asimina Kalogirou, Evangelos Tsiambas, Paraskevi Tziakou, George Tsouvelas, Stylianos Papadopoulos, Michail Mitsis, Marilena Lekka, Despoina Spyropoulou, Konstantinos Vlachos; pp 2430-2434 (Pubmed Abstract, PDF)

GASTRIC CANCERS

Super enhancer-associated CCAT1 lncRNA promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in gastric cancer
Lingzhi Peng, Tianxiang Liu, Chenglou Zhu, Chongya Yang, Qiong Wang, Mingxu Da; pp 2435-2445 (Pubmed Abstract, PDF)

Analysis on safety and efficacy of low-dose apatinib combined with paclitaxel as second-line treatment for advanced gastric cancer
Yang Xue-Jing, Song Dong, Yang Xiao-Ling, Guo Xin; pp 2445-2451 (Pubmed Abstract, PDF)

Association between high initial CEA, CA 19-9 levels and HER-2 status and their prognostic values on overall survival in metastatic gastric cancer
Fatih Selcukbiricik, Kayhan Erturk, Emre Balık, Buket Bayram Kuvvet, Melisa Celayir, Farid Babashov, Deniz Tural, Begum Guler Sentürk, Nil Molinas Mandel; pp 2452-2456 (Pubmed Abstract, PDF)

LUNG CANCERS

Comparison of response and survival of first-line crizotinib therapy according to EML-4 ALK fusion variants in advanced non-small cell lung cancer patients: A Turkish Oncology Group study
Ali Murat Tatli, Perran Fulden Yumuk, Buge Oz, Ahmet Bilici, Pınar Gursoy, Erdem Goker, Ahmet Sezer, Ahmet Ozet, Umut Demirci, Emine Bozkurtlar, Irem Hicran Ozbudak, Deniz Nart, Tugba Canpolat, Nalan Akyurek, Saadettin Kilickap; pp 2457-2464 (Pubmed Abstract, PDF)

NTF4 promoted the malignant progression of NSCLC by negatively regulating FOXL1
Lin Mu, Hong Zhao, Yifeng Zhang, Chun Xiao; pp 2465-2469 (Pubmed Abstract, PDF)

Clinical analysis of anlotinib in the third-line treatment of advanced non-small cell lung cancer
Wenrui Jiang, Xing Tang, Yuan Fang, Shuo Wu, Fang Yang; pp 2470-2476 (Pubmed Abstract, PDF)

PANCREATIC CANCERS

Efficacy of modified FOLFIRINOX neoadjuvant chemotherapy combined with surgery on resectable pancreatic cancer
Xiang Feng, Yuyao Liu, Tiantian Zhao, Yawen Gao; pp 2477-2483 (Pubmed Abstract, PDF)

Prognostic factors and prognostic index for patients with advanced pancreatic cancer. Single center experience and review of the literature
Ilkay Tugba Unek, Tarkan Unek, Dogan Koca, Tulay Akman, Tarik Salman, Hulya Ellidokuz, Olcun Umit Unal, Ilhan Oztop, Funda Obuz, Ugur Yilmaz; pp 2484-2495 (Pubmed Abstract, PDF)

Combination of gemcitabine, infusional 5-fluorouracil and high-dose folinic acid (GEMFUFOL) as adjuvant chemotherapy in resected pancreatic cancer
Ilkay Tugba Unek, Ilhan Oztop, Dogan Koca, Tarkan Unek, Anil Aysal Agalar, Zeynep Gulsum Guc, Sinan Unal, Zumre Arican Alicikus, Asim Leblebici, Hulya Ellidokuz, Ozgul Sagol, Ugur Yilmaz; pp 2496-2504 (Pubmed Abstract, PDF)

CNS TUMORS

Clinical application of patient derived xenograft mouse model in children with neuroblastoma
Keke Chen, Zhijun Huang, Xianbo Shen, Xin Tian, Chengguang Zhu, Qin Shi, Minhui Zen, Zexi Yin, Xiangling He; pp 2505-2514 (Pubmed Abstract, PDF)

Vitamin C through upregulating SYNPO2 level suppresses the proliferation and migration of glioma cells
Yishuo Zhu, Xuan Wang, Yujie Cui, Jin Bai, Junnian Zheng, Yuechao Fan; pp 2515-2520 (Pubmed Abstract, PDF)

GERM CELL TUMORS

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors
Jale Yildiz, Bahar Uncu Ulu, Tugce Nur Yigenoglu, Semih Basci, Mehmet Bakirtas, Derya Sahin, Tahir Darcin, Hikmetullah Batgi, Nuran Ahu Baysal, Dicle Iskender, Alparslan Merdin, Merih Kizil Cakar, Mehmet Sinan Dal, Fevzi Altuntas; pp 2521-2526 (Pubmed Abstract, PDF)

Clinicopathological characteristics and prognosis of testicular mixed teratoma and seminoma: A population-based study
Caibin Fan, Jianqing Wang, Hexing Yuan, Kai Li; pp 2527-2535 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center
Miljan S. Krstic, Slavica M. Stojnev, Ivan Z. Petkovic, Irena K.Conic, Janko T. Zujovic, Velimir S. Milosevic; pp 2536-2543 (Pubmed Abstract, PDF)

Galectins in acute myeloid leukemia: gene expression profiling with clinical emphasis
Mahmoud M. Abdelfattah, Magda M. Assem, Asmaa A. El Leithy, Rasha Mahmoud Allam, Naglaa M. Hassan, Reham Helwa; pp 2544-2552 (Pubmed Abstract, PDF)

PROSTATE CANCER

LncARSR promotes prostate cancer proliferation by activating PTEN/PI3K/Akt pathway
Gang Liu, Jingjun Zhang, Mingyong Liu, Zhiqiang Sun, Hanwen Cui; pp 2553-2558 (Pubmed Abstract, PDF)

Significance of prostate health index and its density to predict aggressive prostate cancer at final pathology
Marija Barisiene, Arnas Bakavicius, Diana Stanciute, Jolita Jurkeviciene, Arunas Zelvys, Albertas Ulys, Dalius Vitkus and Feliksas Jankevicius; pp 2559-2565 (Pubmed Abstract, PDF)

RENAL CELL CARCINOMAS

PD-L1 protein expression patterns in renal cell carcinoma based on conventional and digitized evaluation
Paraskevi Tziakou, Grigorios Theodoropoulos, Evangelos Tsiambas, Gerasimos Kollaitis, Eirini Thymara, Nikolaos Kavantzas, Andreas C. Lazaris; pp 2566-2570 (Pubmed Abstract, PDF)

First-line pazopanib in metastatic renal cell carcinoma: Multicenter experience
Oyman Abdilkerim, Ozcelik Melike, Basak Mustafa, Gokyer Ali, Mahmut Emre Yildirim; pp 2571-2576 (Pubmed Abstract, PDF)

BLADDER CANCER

Assessment of ex-vivo efficacy of immunotherapeutic agents in intermediate-risk and high-risk non-muscle invasive bladder cancer
Serdar Celik, Aylin Erol, Ozde Gokbayrak, Hilmi Sari, Batuhan Yilmaz, Mehmet Ugur Mungan, Kutsal Yorukoglu, Guven Aslan, Ilhan Celebi, Zekiye Altun, Tugba Yavuzsen, Safiye Aktas; pp 2577-2584 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

Hypoxia signature associated with tumor immune microenvironment in the esophageal squamous cell carcinoma
Wujun Zheng; pp 2585-2593 (Pubmed Abstract, PDF)

HEAD & NECK CANCER

Different influences of risk factors on the development of head and neck tumors and other oncological diagnoses
Lickova Katerina, Ambrus Miloslav, Klezl Petr, Vranova Jana, Kratka Zuzana, Cocek Ales; pp 2594-2603 (Pubmed Abstract, PDF)

MELANOMA

MiR-22 alleviates the proliferation and metastasis of melanoma by targeting FASN
Jun Qiu, Yanhua Yi, Yong Miao, Zhiqi Hu; pp 2604-2609 (Pubmed Abstract, PDF)

ORAL CANCER

c-Jun alterations in oral squamous cell carcinoma
Nicholas Mastronikolis, Evangelos Tsiambas, Panagiotis P Fotiades, Efthymios Kyrodimos, Aristeidis Chrysovergis, Vasileios Papanikolaou, Dimitrios Roukas, Asimakis Asimakopoulos, Sofianiki Mastronikoli, Vasileios Ragos; pp 2610-2612 (Pubmed Abstract, PDF)

RETINOBLASTOMA

Effects of long non-coding RNA MALAT1 targeting miR-570-3p and miR-34a on invasion, proliferation and apoptosis of human retinoblastoma cells
Dejing Shi, Xiuhong Feng, Xuchen Ding; pp 2613-2620 (Pubmed Abstract, PDF)

THYROID CANCER

Radioactive iodine treatment planning for differentiated thyroid carcinoma: Comparison of different machine learning classification models
Marina Popovic, Dragana Sobic Saranovic, Milos Nikolic, Dusan Teodorovic, Ivan Markovic, Ljiljana Mijatovic Teodorovic; pp 2621-2628 (Pubmed Abstract, PDF)

URINARY CANCER

The prognostic impact of ABO blood groups and Rhesus factor in patients with upper tract urothelial carcinoma
Djordje Radisavcevic, Zoran Dzamic, Emre Cico, Sandra Sipetic Grujicic, Bogomir Milojevic; pp 2629-2634 (Pubmed Abstract, PDF)

MISCELLANEOUS

A new protocol of desensitization for systemic therapy agents in oncology
Calin Cainap, Sanziana Cetean, Andrei Havasi, Ovidiu Crisan, Ovidiu Balacescu, Laura Ancuta Pop, Loredana Balacescu, Andra Piciu, Alexandru Mester, Doina Piciu, Adina Stan, Alina Bereanu, Catalin Vlad, Patriciu Achimas, Simona Cainap; pp 2635-2642 (Pubmed Abstract, PDF)

Functional neuroctomy in tumor-related and idiopathic trigeminal neuralgia
Vasileios Ragos, Asimakis Asimakopoulos, Evangelos Tsiambas, George Papanastasiou, George Argyris, Athanasios Niotis, Panagiotis Fotiades, George Psychogios; pp 2643-2647 (Pubmed Abstract, PDF)

Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC) in the treatment of primary and metastatic pleural malignancies – is extension of indications possible?
Dejan Stojiljkovic, Nada Santrac, Dijana Mircic, Dusan Ristic, Tanja Stojiljkovic, Ana Cvetkovic; pp 2648-2653 (Pubmed Abstract, PDF)

Breast, ovarian and other site cancer patients with BRCA 1/2 mutations: Data from Turkish multicenter retrospective study
Osman Kostek, Ahmet Kucukarda, Hilmi Tozkir, Ilker Nihat Okten, Ercan Ozden, Devrim Cabuk, Murat Sari, Emre Cakir, Ilhan Hacibekiroglu, Mustafa Gurbuz, Yuksel Urun, Bahiddin Yilmaz, Cihan Erol, Mehmet Ali Nahit Sendur, Emrah Eraslan, Umut Demirci, Zeynep Oruc, Mehmet Ali Kaplan, Ali Gokyer, Ivo Gokmen, Erkan Ozcan, Muhammet Bekir Hacioglu, Bulent Erdogan, Selma Demir, Sernaz Uzunoglu, Mahmut Gumus, Hakan Gurkan, Irfan Cicin; pp 2654-2661 (Pubmed Abstract, PDF)

Corrected QT prolongation among chemotherapy – treated patients: A study of a Romanian center
Cristina Crisan, Calin Cainap, Anca Farcas, Tiberiu Moldovan, Eduard Radu, Ovidiu Bochis, Gabriela Morar-Bolba, Adina Stan, Alina Bereanu, Catalin Vlad, Patriciu Achimas, Simona Căinap; pp 2662-2667 (Pubmed Abstract, PDF)

Chemotherapy in cholangiocarcinoma – experience of a tertiary cancer center from Romania
Catalin Vlad, Andrei Havasi, Patriciu Achimas, Calin Cainap, Laura Pop, Daniel Sur, Andra Piciu, Andra Stan, Alina Bereanu, Florina Gabor-Harosa, Iulia Zehan, Ana Teodora Havasi, Simone Cainap; pp 2668-2677 (Pubmed Abstract, PDF)

Inmate cancer patient – Highlighting the importance of a holistic approach to oncological care
Maria Tolia, Emmanouil K.Symvoulakis, Konstantinos Kamposioras, Davide Mauri, Angeliki Skoutari, Panagiotis Volkos, Dimitrios Schizas, Athanasios Spanos, Ioannis Kokakis, Nikolaos Tsoukalas, Nikolaos Charalampakis, Francesco Cuccia, Filippo Alongi, Ramon Andrade de Mello, Katerina M Antoniou, Thomas Hyphantis, Ioanna Nixon, Dimitris Matthaios, Michail Nikolaou, Francesco de Lorenzo, Kathi Apostolidis; pp 2678-2693 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: is it too early to reach conclusion?
Ahmet N.Sanli, Kadri Altundag; p 2694 (Pubmed Abstract, PDF)

Microsatellite instability (MSI) markers in thyroid carcinoma
Nicholas Mastronikolis, Aristeidis Chrysovergis, Evangelos Tsiambas, Efthymios Kyrodimos; p 2694 (Pubmed Abstract, PDF)

Regular daily weighted Hula-Hooping might reduce central adiposity leading to decreased pre- and postmenopausal breast cancers risk
Ahmet N.Sanli, Kadri Altundag; p 2695 (Pubmed Abstract, PDF)

SARS-CoV-2 implication in retinoblastoma
Claire Konstantopoulou, Dimitrios Roukas, Paraskevi Tziakou, Evangelos Tsiambas; p 2696 (Pubmed Abstract, PDF)

Synchronous breast cancer metastases both to parotid and thyroid glands: a rare presentation
Ahmet N.Sanli, Kadri Altundag; p 2697 (Pubmed Abstract, PDF)

P53/MDM-2 gene alterations in laryngeal squamous cell carcinoma
Vasileios Papanikolaou, Efthymios Kyrodimos, Evangelos Tsiambas, Aristeidis Chrysovergis; p 2697 (Pubmed Abstract, PDF)

Solitary radius metastasis in a breast cancer patient: a rare presentation
Ahmet N.Sanli, Kadri Altundag; p 2698 (Pubmed Abstract, PDF)

Triple negative apocrine breast cancer with atypical metastatic presentations
Kadri Altundag; p 2699 (Pubmed Abstract, PDF)

Microsatellite instability in oral squamous cell carcinoma
Efthymios Kyrodimos, Aristeidis Chrysovergis, Evangelos Tsiambas, Vasileios S.Papanikolaou; p 2699 (Pubmed Abstract, PDF)

Isolated contralateral axillary lymph node recurrence in breastcancer
Kadri Altundag; pp 2700-2701 (Pubmed Abstract, PDF)

RETRACTIONS

PMID: 32277651; p 2702 (Pubmed Abstract, PDF), PMID: 27569081; p 2703 (Pubmed Abstract, PDF), PMID: 32277652; p 2704 (Pubmed Abstract, PDF), PMID: 32277672; p 2705 (Pubmed Abstract, PDF), PMID: 32521867; p 2706 (Pubmed Abstract, PDF), PMID: 32521859; p 2707 (Pubmed Abstract, PDF), PMID: 33099911; p 2708 (Pubmed Abstract, PDF), PMID: 32277648; p 2709 (Pubmed Abstract, PDF), PMID: 30941961; p 2710 (Pubmed Abstract, PDF), PMID: 30941973; p 2711 (Pubmed Abstract, PDF), PMID: 31128046; p 2712 (Pubmed Abstract, PDF), PMID: 31646794; p 2714 (Pubmed Abstract, PDF), PMID: 27061538; p 2715 (Pubmed Abstract, PDF), PMID: 26854446; p 2716 (Pubmed Abstract, PDF)